I recently looked at a list of market targets that is, frankly, completely devoid of logic. It looks like someone put on a blindfold, threw darts at a Wall Street board, and decided to group everything they hit—from crypto shell companies and toothpaste manufacturers to gold ETFs. This is stupid and here's why.

Why aren't you moving with more clarity? When market capital simultaneously floods into completely unrelated sectors, it tells me that nobody has a clue what to bet on next. Let's go through this chaotic kitchen sink and see who is actually doing the work, and who is just pretending to be awake.

Let's start with the trend-chasers. Nakamoto Games (NAKA.US) decided in mid-2026 to shut down its traditional medical clinics and completely pivot to a Bitcoin operating company, rolling over roughly 105M USDT in debt. Good luck with that. This plays exactly like the late 90s when everyone just added ".com" to their names. Then there's Gaotu Techedu (GOTU.US), which is surviving on non-academic tutoring, posting RMB 1.67B in net revenue for Q2 2026, up 20.2% year-over-year. Management bought back over RMB 741M in stock to prove they are still in the game.

Then we have the legacy players putting on the AI cape, but at least showing real numbers. IQVIA Holdings (IQV.US) and Natera (NTRA.US) are actually delivering in healthcare and gene testing. IQVIA pulled in USD 4.4B in Q2 2026 revenue and snagged a 2026 AI Breakthrough Award. Natera saw its oncology tests grow by 57.2%, driving total revenue up to USD 752.8M. These two are among the few in this blind box with actual fundamental backing.

As for tech and data infrastructure, Pure Storage (PSTG.US) is doing what it should be doing. Q2 FY2027 revenue surged 38% to USD 1.186B, and they secured another top-five hyperscaler client. This is what execution looks like—fewer gimmicks, more actual subscription growth.

The rest of this list is basically a retirement fund's panic cart. You have Colgate-Palmolive (CL.US) selling toothpaste, reporting Q2 net sales of USD 5.36B and faithfully paying out its USD 0.53 dividend. Then you throw in the iShares Gold Trust Micro (IAUI.US) with its USD 6.81B market cap, and the Vanguard Global ex-U.S. Real Estate ETF (VGZ.US) offering a 4.74% dividend yield. Tacking on the iM DBi Managed Futures Strategy ETF (DBMF.US) with its USD 4.07B AUM and the practically invisible Axtra Long-Short Equity Fund (AXTC.US) just turns this into a directionless hedging exercise.

My view is clear: When a portfolio relies on Colgate's toothpaste and Nakamoto's Bitcoin pivot at the same time, that's not diversification—it's schizophrenia. Stop throwing money at these disjointed dartboards and focus on the actual winners with real cash flow and AI execution capabilities.

This article does not constitute investment advice.